Parmax Pharma Board Meeting on June 8 for Fund Raising Approval

Parmax Pharma Ltd has announced a Board of Directors meeting scheduled for June 8, 2026. The primary agenda is to consider and approve a proposal for raising funds through various methods, including preferential issue via private placement or other eligible securities. The company will also decide on the date and place for an Extraordinary General Meeting (EGM) to seek shareholder approval for the fund-raising plan. Concurrently, the trading window for designated persons will be closed from June 3, 2026, until 48 hours after the board meeting concludes.